Oruka Therapeutics, Inc.
ORKA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000907654
In the last 90 days, Oruka Therapeutics, Inc. insiders filed 0 open-market purchases and 15 sales; 255 institutions reported holding it in 13F filings for Q2 2026, worth $7.05B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Oruka Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 876.8K | 1.19M | +316.8K (+36.1%) |
| Value | $3.20M | $4.16M | +$967.0K (+30.2%) |
New holders (5)
Institutions that held Oruka Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 69,037 | $241.0K | 0.00% |
| Goldman Sachs Group Inc | 13,918 | $49.0K | 0.00% |
| XTX Topco Ltd | 10,846 | $38.0K | 0.01% |
| UBS Group AG | 5,365 | $19.0K | 0.00% |
| JPMorgan Chase & Co | 133 | $0 | 0.00% |
Sold out (5)
Institutions that held Oruka Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Morgan Stanley | 40,744 | $149.0K |
| PDT Partners, LLC | 17,297 | $63.0K |
| Virtu Financial LLC | 16,655 | $61.0K |
| Simplex Trading, LLC | 11,121 | $40.0K |
| Group One Trading, L.P. | 2,168 | $8.00K |